|
⚲
|
| Keyboard |
| LOAR Matthew M
✚
|
|
|---|---|
| CIK # | 0001236260 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001236260] | |
| 4 | [0001236260] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mateon Therapeutics Inc | |
| LOAR Matthew M | |
| Transcept Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mateon Therapeutics Inc MATN
Employee Stock Option (Right to Buy) · derivative
|
2018-06-20 | Grant | 250,000 | $0.00 | |
|
Mateon Therapeutics Inc MATN
Employee Stock Option (Right to Buy) · derivative
|
2018-06-20 | Grant | 500,000 | $0.00 | |
|
Mateon Therapeutics Inc MATN
Common Stock
|
2018-04-12 | Buy | 250,000 | ||
|
Mateon Therapeutics Inc MATN
Common Stock A Warrant (Right to Buy) · derivative
|
2018-04-12 | Buy | 125,000 | ||
|
Mateon Therapeutics Inc MATN
Common Stock B Warrant (Right to Buy) · derivative
|
2018-04-12 | Buy | 125,000 | ||
|
Mateon Therapeutics Inc MATN
Employee Stock Option (Right to Buy) · derivative
|
2017-01-12 | Grant | 350,000 | $0.38 | 133,000 |
|
Mateon Therapeutics Inc OXGN
Employee Stock Option (Right to Buy) · derivative
|
2016-03-21 | Grant | 262,500 | $0.00 | |
|
Mateon Therapeutics Inc OXGN
Employee Stock Option (Right to Buy) · derivative
|
2015-07-20 | Grant | 150,000 | $0.00 | |
|
Transcept Pharmaceuticals Inc TSPT
Stock Option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 2,083 | ||
|
Transcept Pharmaceuticals Inc TSPT
Common Stock (right to buy) · derivative
|
2013-12-16 | Grant | 25,000 | $0.00 |